0000880771-16-000193.txt : 20160929 0000880771-16-000193.hdr.sgml : 20160929 20160929202017 ACCESSION NUMBER: 0000880771-16-000193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160929 FILED AS OF DATE: 20160929 DATE AS OF CHANGE: 20160929 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHANG NANCY T CENTRAL INDEX KEY: 0001135041 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 161911112 MAIL ADDRESS: STREET 1: 101 WESTCOTT STREET 2: SUITE 603 CITY: HOUSTON STATE: TX ZIP: 77007 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2016-09-29 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001135041 CHANG NANCY T 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404-2125 1 0 0 0 Common Stock 2016-09-29 4 M 0 7648 5.1 A 36667 D Common Stock 2016-09-29 4 M 0 33333 5.22 A 70000 D Non-Qualified Stock Option (right to buy) 5.1 2016-09-29 4 M 0 7648 0 D 2024-06-12 Common Stock 7648 0 D Non-Qualified Stock Option (right to buy) 5.22 2016-09-29 4 M 0 33333 0 D 2023-06-17 Common Stock 33333 0 D Granted under the Issuer's 2005 Equity Incentive Plan. Each option shall vest and become exercisable at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant except that, in the event of a change in control, any unexercisable or unvested portions of outstanding options shall be immediately exercisable and vested in full as of the date ten (10) days prior to the change in control, regardless of whether the option is assumed or substituted for by the acquirer. Shares will become exercisable in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Outside Director's continuous service on Issuer's Board of Directors. /s/ Friedhelm Blobel, Attorney-in-Fact For: Nancy T. Chang 2016-09-29